Evaluation of Lung Ultrasound in Acute Heart Failure
ELUSIA
Evaluation of Lung UltraSound In Acute Heart Failure (ELUSIA)
1 other identifier
observational
56
1 country
1
Brief Summary
Acute heart failure is a life threatening condition requiring rapid diagnosis and treatment. However, the differentiation between heart failure and other conditions presenting with acute dyspnea is notoriously difficult in the emergency room. Point-of-care lung ultrasound is a simple, rapid and noninvasive technique directly visualizing fluid content in the lung as evidence for acute heart failure. A number of publications showed the diagnostic utility of lung ultrasound in the diagnosis of heart failure, but many open questions remain. The goal of this study is to evaluate the diagnostic accuracy of lung ultrasound to predict a cardiac origin of dyspnea in unselected patients in the emergency room as compared to standard evaluation. Further goals are to evaluate if lung ultrasound provides additional diagnostic information as compared to clinical examination, NT-proBNP and chest X-ray, to compare the diagnostic accuracy of lung ultrasound in different patient subgroups (heart failure with preserved vs reduced ejection fraction, de novo vs decompensated chronic heart failure, age ≥75 vs \<75 years, women vs men and presence vs absence of concomitant pulmonary disease) and to compare demographics and clinical characteristics in different patient populations. 300 patients, aged ≥18 years presenting to the emergency room (ER) with acute dyspnoe as principal complaint will undergo initial clinical assessment of the likely etiology of dyspnea by the ER physician in charge. The second assessment by the same physician will include results of NT-proBNP according to predefined cutoffs. Final diagnosis ("Gold Standard") will be done by two experienced investigators after patient discharge taking into account the complete medical record except the results of lung ultrasound. Assessment of chest X-ray and lung ultrasound by investigators will be preforemd blinded regarding all other results.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 4, 2017
CompletedFirst Posted
Study publicly available on registry
August 9, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2018
CompletedSeptember 19, 2019
September 1, 2019
2.6 years
August 4, 2017
September 18, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Value of lung ultrasound in the diagnosis of acute heart failure
Presence/Absence of heart failure
at the time of inclusion into the study
Interventions
Point-of-care ultrasound exam of both lungs in 4 predefined zones.
Eligibility Criteria
Unselected patients presenting with this acute dyspnea to the emergency department.
You may qualify if:
- Emergency room presentation with acute dyspnoe as principal complaint (either new or worsening in the last 48 hours) Age ≥18 years.
You may not qualify if:
- Immediately life threatening condition (cardiac arrest, ST-elevation myocardial infarction, shock, respiratory failure requiring intubation) No consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cantonal Hospital Baselland
Bruderholz, Basel-Landschaft, 4101, Switzerland
Biospecimen
Standard laboratory samples for blood cell count, blood chemistry including NT-proBNP
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Rickenbacher, MD
Cantonal Hospital Baselland
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Institutional Head
Study Record Dates
First Submitted
August 4, 2017
First Posted
August 9, 2017
Study Start
March 1, 2016
Primary Completion
September 30, 2018
Study Completion
September 30, 2018
Last Updated
September 19, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share